MGB Wealth Management LLC Sells 1,604 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

MGB Wealth Management LLC trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 36.4% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,800 shares of the financial services provider’s stock after selling 1,604 shares during the period. MGB Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $370,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in IBB. Darwin Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the third quarter worth about $29,000. Highline Wealth Partners LLC purchased a new position in shares of iShares Biotechnology ETF in the third quarter worth approximately $30,000. HHM Wealth Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares during the last quarter. Newbridge Financial Services Group Inc. bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $33,000. Finally, Hager Investment Management Services LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter valued at approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.9 %

IBB opened at $135.47 on Thursday. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57. The firm’s 50 day simple moving average is $135.88 and its two-hundred day simple moving average is $141.13.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.